Huang Yu-Ting, Lin Hsiang-Yu, Wang Chung-Hsing, Su Bai-Horng, Lin Che-Chen
Department of Neonatology, China Medical University Children's Hospital, Taichung, Taiwan; School of Medicine, China Medical University, Taichung, Taiwan.
Department of Genetics and Metabolism, China Medical University Children's Hospital, Taichung, Taiwan; School of Medicine, China Medical University, Taichung, Taiwan.
Pediatr Neonatol. 2018 Apr;59(2):147-153. doi: 10.1016/j.pedneo.2017.07.007. Epub 2017 Jul 25.
Previous studies have identified preterm birth and/or small for gestational age (SGA) as risk factors for features of the metabolic syndrome, including high blood pressure, insulin sensitivity and atherosclerosis, occurring later in life, with controversial results. We conducted this population-based cohort study to investigate metabolic outcomes in those with former preterm birth and/or SGA status in Taiwan.
Data were obtained from Taiwan's universal National Health Insurance Research Database. From 1996 to 2004, 37,119 preterm infants, 3386 SGA infants, and 162,020 matched controls were included. We investigated the risk of the metabolic disease, including hypertension, diabetes, and hyperlipidemia, which had been recorded by the end of 2008.
The preterm and SGA cohort, combined into one, had a significantly increased risk of developing metabolic disorders when compared with the comparison cohort (HR = 2.46, 95% CI = 2.02-3.01). We observed that children with former preterm and SGA status in Taiwan had a higher risk of developing hypertension (HR = 3.24, 95% CI = 1.58-6.67), Type 1 diabetes mellitus (HR = 1.80, 95% CI = 1.05-3.07), Type 2 diabetes mellitus (HR = 2.49, 95% CI = 1.98-3.14), and hyperlipidemia (HR = 2.14, 95% CI = 1.29-3.52).
Our study revealed the risk of metabolic disease in those with preterm birth and/or SGA. Further studies with a longer duration of follow-up are required to confirm if there is a tendency for the metabolic syndrome to develop in this study cohort.
先前的研究已将早产和/或小于胎龄儿(SGA)确定为代谢综合征特征(包括高血压、胰岛素敏感性和动脉粥样硬化)在生命后期出现的风险因素,但结果存在争议。我们开展了这项基于人群的队列研究,以调查台湾地区曾有早产和/或SGA状况者的代谢结局。
数据取自台湾全民健康保险研究数据库。纳入了1996年至2004年间的37119名早产儿、3386名小于胎龄儿以及162020名匹配对照。我们调查了截至2008年底记录的代谢性疾病风险,包括高血压、糖尿病和高脂血症。
早产和SGA队列合并后,与对照队列相比,发生代谢紊乱的风险显著增加(风险比[HR]=2.46,95%置信区间[CI]=2.02-3.01)。我们观察到,台湾地区曾有早产和SGA状况的儿童患高血压(HR=3.24,95%CI=1.58-6.67)、1型糖尿病(HR=1.80,95%CI=1.05-3.07)、2型糖尿病(HR=2.49,95%CI=1.98-3.14)和高脂血症(HR=2.14,95%CI=1.29-3.52)的风险更高。
我们的研究揭示了早产和/或SGA者患代谢性疾病的风险。需要进行更长随访期的进一步研究,以确认该研究队列中是否存在代谢综合征发展的趋势。